Home › NDC Lookup › RxCUI directory › RxCUI 2197495

Fedratinib 100 MG Oral Capsule — RxCUI 2197495

RxNorm drug concept · Semantic clinical drug
RxCUI 2197495 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2197495
Official nameFedratinib 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfedratinib (as fedratinib dihydrochloride 117.3 MG) 100 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fedratinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Myelofibrosis is a type of bone marrow cancer where scar tissue builds up in the marrow, disrupting normal blood cell production and often causing an enlarged spleen, fatigue, and...
  • What exactly is myelofibrosis, and why was I prescribed Inrebic for it?
  • This is genuinely important — Inrebic has been linked to a serious, potentially fatal brain condition called Wernicke's encephalopathy, which is caused by a deficiency in thiamine...
  • Why do I have to take a vitamin B1 supplement every day with this medication?
📖 Read our full Fedratinib guide →

🕸️ Concept Web — How Fedratinib 100 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fedratinib 100 MG Oral Capsule RxCUI 2197495

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fedratinib 2197490
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Inrebic 2197496
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fedratinib Oral Capsule 2197494
    • Fedratinib Oral Product 2197492
    • Fedratinib Pill 2197493
    • Fedratinib Oral Capsule [Inrebic] 2197498
    • Inrebic Oral Product 2197499
    • Inrebic Pill 2197500
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fedratinib 100 MG SCDC · 2197491
  • Fedratinib Oral Capsule SCDF · 2197494
  • Fedratinib Oral Product SCDG · 2197492
  • Fedratinib Pill SCDG · 2197493

Brand-Name Concepts

  • Fedratinib 100 MG Oral Capsule [Inrebic] SBD · 2197501
  • Fedratinib 100 MG [Inrebic] SBDC · 2197497
  • Fedratinib Oral Capsule [Inrebic] SBDF · 2197498
  • Inrebic Oral Product SBDG · 2197499
  • Inrebic Pill SBDG · 2197500
  • Inrebic BN · 2197496

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2197495 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59572-0720-12 120 CAPSULE in 1 BOTTLE, PLASTIC (59572-720-12) Inrebic Celgene Corporation 2019-08-16
Observed labelers: Celgene Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.